3 Monster Dividend Stocks to Hold for the Next 10 Years

The article recommends three dividend stocks for long-term 10-year investors: Clorox (strengthened by its Purell acquisition and offering a 5% yield), Brown-Forman (with 42 consecutive years of dividend increases and a 3.6% yield despite current market softness), and Kimberly-Clark (undergoing major transformation with trusted brands and 50+ years of dividend growth). All three are positioned as overlooked opportunities for patient investors seeking steady compounding returns.

06/21/2026, 3:05 AM • The Motley Fool

Where to Put $1,000 When the Market Is This Uncertain

In an uncertain market marked by tariff-driven inflation and low consumer sentiment, the article recommends three consumer staples companies as stable investments for a $1,000 allocation: Church & Dwight for its volume-driven growth, Keurig Dr Pepper for its high-growth energy drink portfolio, and Kenvue for its strong beauty and health brands ahead of its merger with Kimberly-Clark.

06/20/2026, 4:05 AM • The Motley Fool

Kimberly-Clark vs. The Clorox: Which Consumer Goods Stock Is a Better Buy in 2026?

The article compares Kimberly-Clark and Clorox as investment options for 2026. Both companies face challenges including high debt loads, customer concentration risk (Walmart accounts for 16-27% of sales), and intense competition. Kimberly-Clark is undergoing significant restructuring with a potential $48 billion merger with Kenvue and selling its international tissue business, while Clorox is recovering from a 2023 cyberattack and pandemic-era slowdown. The author recommends Clorox as the safer choice due to its stronger brand positioning, though acknowledges Kimberly-Clark offers higher upside potential despite greater integration risks.

05/28/2026, 4:17 PM • The Motley Fool

These 3 Dividend Stocks Have Made Investors Rich. They Can Do It Again.

Three consumer goods dividend stocks are positioned for growth: Hershey benefits from a 74% drop in cocoa prices enabling margin expansion; General Mills offers a 7% yield amid transformation and cost structure improvements; Kimberly-Clark is acquiring Kenvue to create a scaled personal-care platform with strong brands and long-term dividend durability.

05/07/2026, 8:15 AM • The Motley Fool

The Best Dividend Stock to Own During a Market Crash

Kimberly-Clark is recommended as a defensive dividend stock for potential market downturns due to its essential consumer staples products, 54-year dividend increase streak, and attractive 5.2% yield. Despite a 30% stock price decline from its June high due to the $48.7 billion Kenvue acquisition financing concerns, the stock's low P/E ratio of 15 and strong free cash flow support suggest limited downside risk.

05/05/2026, 2:30 PM • The Motley Fool

Billionaire Investor Cuts Tylenol Maker Kenvue Stake By 64%

Hedge fund billionaire Daniel Loeb reduced his stake in Kenvue Inc. by 64% in Q4 2025, cutting holdings from 9.0 million to 3.25 million shares. The consumer health company, which includes brands like Tylenol and Listerine, is undergoing a restructuring that will reduce workforce by 3.5% with $250 million in charges expected in 2026. Kenvue's acquisition by Kimberly-Clark at $48.7 billion enterprise value is expected to close in H2 2026 pending regulatory approval.

04/24/2026, 2:19 PM • Benzinga

The Smartest Dividend Stocks to Buy With $2,000 Right Now

The article recommends three dividend stocks for investors seeking income: PepsiCo, which is showing signs of recovery after underperformance; Kenvue, a spinoff from Johnson & Johnson offering reliable recurring income with an upcoming merger; and Procter & Gamble, a consumer staples giant with 70 consecutive years of dividend increases.

04/19/2026, 4:05 PM • The Motley Fool

Looking for a High-Yield Alternative to Costco Wholesale and Walmart? Consider This Dirt Cheap Dividend King Stock.

While Costco and Walmart have delivered strong returns, their valuations are stretched with forward P/E ratios of 48.7 and 43.4 respectively, and low dividend yields of 0.5% and 0.8%. Kimberly-Clark offers a compelling alternative with a 5.3% dividend yield, 54 consecutive years of dividend increases, and a cheap valuation at 12.8x forward earnings. The company's strategic exit from low-margin private-label diapers and planned acquisition of Kenvue (adding brands like Band-Aid and Tylenol) position it for margin expansion and dividend growth.

04/15/2026, 1:15 PM • The Motley Fool

The 3 Highest-Yielding Dividend Kings in April

Three Dividend Kings—Altria, Universal Corporation, and Kimberly-Clark—currently offer the highest dividend yields among elite dividend stocks that have increased dividends for 50+ consecutive years. Altria yields 6.3% but faces declining cigarette demand in North America. Universal yields 6.1% as a global tobacco supplier with stronger international demand. Kimberly-Clark yields 5.2% and is pursuing a growth strategy through its acquisition of Kenvue, though this carries integration risks. All three are considered riskier investments suitable primarily for aggressive investors.

04/12/2026, 10:15 AM • The Motley Fool

Could Buying This Dividend Pharma Stock Today Set You Up for Life?

Johnson & Johnson is highlighted as an exceptional dividend stock for retirees, boasting a 63-year dividend-increase streak as a Dividend King. The diversified healthcare company combines pharmaceutical and medical device businesses, with an AAA credit rating ensuring dividend stability. However, its 2.2% yield, while double the S&P 500's 1.1%, falls short of the 4% target many dividend investors seek.

04/09/2026, 8:15 PM • The Motley Fool

Looks Like M&A Week in 3 Different Sectors

A major M&A week sees Sysco acquiring Restaurant Depot for $26 billion and McCormick merging with Unilever's food division for $44 billion, while Eli Lilly acquires Centessa Pharmaceuticals for $7.8 billion. The podcast discusses the track record of consumer brand mergers (mostly unsuccessful) and analyzes Whirlpool as a dividend investment amid housing market headwinds.

04/08/2026, 12:02 PM • The Motley Fool

These 3 Beaten-Down Stocks Haven't Been This Cheap in Over a Decade

Nike, Kimberly-Clark, and Conagra Brands have all declined significantly over the past five years and are trading at valuations not seen in over a decade. While these stocks present potential buying opportunities at low valuations, each faces substantial headwinds: Nike struggles with competition and margin pressure, Kimberly-Clark faces uncertainty from its planned Kenvue acquisition, and Conagra battles weak growth and concerns about dividend sustainability.

04/08/2026, 10:30 AM • The Motley Fool

This Healthcare Stock Barely Flinches During Market Sell-Offs

Johnson & Johnson demonstrates resilience during market downturns, with shares falling less than 2% while the S&P 500 dropped over 7%. The healthcare giant maintains strong fundamentals including 63 consecutive years of dividend increases, $94.2 billion in 2025 revenue (up 6%), and 51 drug approvals last year. However, the stock faces headwinds from tens of thousands of talc-related lawsuits and Medicare drug price negotiations under the Inflation Reduction Act.

04/02/2026, 6:14 AM • The Motley Fool

My Top 3 Dividend Kings to Buy for March 2026

The article highlights three Dividend Kings as strong buy opportunities in March 2026: Genuine Parts (GPC), which recently pulled back after disappointing earnings but offers a 3.7% dividend yield and a potential split-up catalyst; Kimberly-Clark (KMB), which is acquiring Kenvue and expects $2 billion in cost synergies; and Target (TGT), which has rallied significantly but still offers upside potential with a 3.9% dividend yield and strong earnings growth forecasts.

03/10/2026, 12:14 PM • The Motley Fool

Starboard Value Takes Stake in Fluor as Industrial Investment Cycles Reaccelerate

Activist investor Starboard Value LP acquired a 5.19 million share stake in engineering and construction firm Fluor Corporation worth $205.73 million, representing 3.9% of its reportable assets. The investment reflects confidence in Fluor's ability to capitalize on accelerating industrial and energy infrastructure investment cycles, though investors will monitor whether the company can convert its growing project backlog into steady, profitable earnings without cost overruns.

03/04/2026, 3:04 PM • The Motley Fool